These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39243946)

  • 21. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scalp melanoma: Distinctive high risk clinical and histological features.
    Xie C; Pan Y; McLean C; Mar V; Wolfe R; Kelly JW
    Australas J Dermatol; 2017 Aug; 58(3):181-188. PubMed ID: 26768190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of BRAF mutations in primary melanoma growth rate and survival.
    Mar VJ; Liu W; Devitt B; Wong SQ; Dobrovic A; McArthur GA; Wolfe R; Kelly JW
    Br J Dermatol; 2015 Jul; 173(1):76-82. PubMed ID: 25752325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographic region: Does it matter in cutaneous melanoma of the head and neck?
    Kılıç S; Unsal AA; Chung SY; Samarrai R; Kılıç SS; Baredes S; Eloy JA
    Laryngoscope; 2017 Dec; 127(12):2763-2769. PubMed ID: 28581118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.
    El Sharouni MA; Aivazian K; Witkamp AJ; Sigurdsson V; van Gils CH; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    JAMA Dermatol; 2021 Feb; 157(2):166-173. PubMed ID: 33355600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
    Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
    Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
    Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
    Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Margins of excision and prognostic factors for cutaneous eyelid melanomas.
    Harish V; Bond JS; Scolyer RA; Haydu LE; Saw RP; Quinn MJ; Benger RS; Uren RF; Stretch JR; Shannon KF; Thompson JF
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1066-73. PubMed ID: 23688975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
    Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, dermatoscopic, histological and molecular predictive factors of distant melanoma metastasis: A systematic review and meta-analysis.
    Lallas K; Kyrgidis A; Chrysostomidis A; Vakirlis E; Apalla Z; Lallas A
    Crit Rev Oncol Hematol; 2024 Oct; 202():104458. PubMed ID: 39074631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
    Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
    JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
    Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
    Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy in cutaneous head and neck melanoma.
    Evrard D; Routier E; Mateus C; Tomasic G; Lombroso J; Kolb F; Robert C; Moya-Plana A
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1271-1279. PubMed ID: 29552728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
    J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas.
    Manninen AA; Gardberg M; Juteau S; Ilmonen S; Jukonen J; Andersson N; Carpén O
    PLoS One; 2019; 14(4):e0216043. PubMed ID: 31039200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.